Stage IVB Cervical Cancer Completed Phase 2 Trials for Temsirolimus (DB06287)

IndicationStatusPhase
DBCOND0028787 (Stage IVB Cervical Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01026792Temsirolimus in Treating Patients With Cervical Cancer That Is Recurrent, Locally Advanced, Metastatic, or Cannot Be Removed By SurgeryTreatment